Skip to content
The Nexus
DossierENTITY

Princeton, N.J.

Coverage of Princeton, N.J. in the Nexus archive.

Earliest in view: Jun 11 · 13:40 UTCMost recent: Aug 11 · 11:13 UTC
Co-mentioned in this coverage
Kardiganorganization2KARDtopic1Automated Insightsorganization1U.S. IPOtopic1biotechtopic1heart drug developertopic1
Recent coverage
  • BUSINESSAug 11 · 11:13 UTCWTOP DC
    Kardigan: Q2 Earnings Snapshot

    Kardigan Inc. reported a loss of $116.2 million and $4.61 per share for its second quarter. The Princeton, New Jersey-based company noted that adjusted losses came to $2.88 per share.

  • BUSINESSJun 11 · 13:40 UTCQUARTZ
    Heart drug developer Kardigan is targeting a $1.4 billion valuation in its U.S. IPO

    Kardigan, a heart drug developer, is targeting a $1.4 billion valuation through its U.S. IPO. The company plans to raise up to $373.3 million by selling 23.3 million shares priced between $14 and $16 each.

Princeton, N.J. · Dossier · The Nexus